The frequency of regulatory T-cells in Hashimoto’s thyroiditis and Graves’ disease
Open Access
- 27 November 2025
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 26 (1)
Abstract
Till now, the management of autoimmune thyroid diseases (AITD) depends on symptomatic treatment and replacement or anti-thyroid therapy. Uncovering the pathophysiologic mechanisms of autoimmunity provides hope for new insights into management. These new treatments aim to modulate the immune reaction and stop the autoimmune process. T regulatory cells (Tregs) are central in antagonising autoimmunity. This study aimed to compare the number of CD4/CD25/FOXP3 T regulatory cells in the different forms of autoimmune thyroid diseases and in the normal population, and to compare the number of CD4 + CD25 + FOXP3 + T regulatory cells between the different forms of AITD, HT, and GD. Also, to investigate the difference in the number of CD4/CD25/FOXP3 T regulatory cells in AITD associated with allergic disorders on one hand and autoimmune thyroid diseases not associated with allergic disorders on the other hand. This study included 18 patients suffering from Hashimoto’s thyroiditis (HT), 15 patients suffering from Graves’ disease (GD); and, for comparison, the Tregs level was measured in 15 healthy control patients. A statistically significant decrease was found regarding CD4/CD25, CD25/FOXP3 percentages and CD4/CD25/FOXP3 absolute number between patients of AITD and the normal population. The absolute number of CD4/CD25/FOXP3 was lower in the GD group than in HT group. Allergic comorbidities do not influence Tregs percentage or their CD4/CD25/FOXP3 absolute number in any of the AITD forms. Tregs may be a potential therapeutic target for AITD.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Perchlorates in the treatment of hyperthyroidism and thyrotoxicosis: a comprehensive reviewEndocrine, 2024
- EVs vs. EVs: MSCs and Tregs as a source of invisible possibilitiesJournal of Molecular Medicine, 2022
- Helper T Cell 17 and Regulatory T Cell Levels in Peripheral Blood of Newly Diagnosed Patients with Autoimmune Thyroid Disease: A Meta-AnalysisHormone and Metabolic Research, 2022
- Absolute reduction in peripheral regulatory T cells in patients with Graves’ disease and post-treatment recoveryMolecular Immunology, 2022
- Treg cells in health and autoimmune diseases: New insights from single cell analysisJournal of Autoimmunity, 2020
- Commensal epitopes drive differentiation of colonic T regsScience Advances, 2020
- Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapyBest Practice & Research Clinical Endocrinology & Metabolism, 2020
- Distinct pattern of peripheral lymphocyte subsets in Graves’ disease with persistency of anti-TSHR autoantibodiesAutoimmunity, 2019
- The possible role of CD4+CD25highFoxp3+/CD4+IL-17A+ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditisEndocrine, 2015
- Impairment of Regulatory T-Cell Function in Autoimmune Thyroid DiseaseThyroid®, 2013